20th Clinical Trials Innovation Programme: October 26 – 27, 2022

Join World BI and Redenlab for the 20th Clinical Trials Innovation Programme, to learn from experts in the drug development industry.

Hear from CEO Dr Adam Vogel and other leading industry experts exploring the future of clinical trials, patient centricity, and drug development digitalisation post COVID. 26 – 27 October 2022, Boston.

To find out more and register, click here.

Related Post

Redenlab contributes to position paper on advancing digital healthtechnologies for frontotemporal degeneration

  • Posted on 15 May, 2025
    MEDIA RELEASE MELBOURNE, VIC – A major collaborative paper published in Alzheimer’s & Dementia introduces a critical roadmap for the...
    Read more

    KAT6B Overexpression in Mice Causes Aggression, Anxiety, and Epilepsy

    • Posted on 26 March, 2025
      A recent study published in iScience explores the effects of KAT6B overexpression in mice, shedding light on the behavioral implications...
      Read more

      Speech, Language and Non-verbal Communication in CLN2 and CLN3 Batten Disease

      • Posted on 18 February, 2025
        Batten disease, or neuronal ceroid lipofuscinosis (NCL), is a devastating childhood dementia that causes progressive loss of speech, language, and...
        Read more